Home LiteratureArticle Details
PMID: 7441019 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia.

The Journal of infectious diseases ·Vol. 142 ·No. 4 ·1980-10-00 ·Pages 602-7

Yu VL, Felegie TP, Yee RB, Pasculle AW, Taylor FH

Abstract

An abbreviated three-dimensional checkerboard titration method was devised to determine whether synergistic interaction of three antimicrobial agents could be found against multidrug-resistant bacteria. Pseudomonas maltophilia was used as the test organism because of its resistance to most commercially available antimicrobial agents, including those active against Pseudomonas aeruginosa. Three-dimensional isobolograms with concave surfaces were formed when synergy occurred. Triple combinations of gentamicin-carbenicillin-rifampin (mean fractional inhibitory concentration index, 0.32) and trimethoprim/sulfamethoxazole-carbenicillin-rifampin (mean fractional inhibitory concentration index, 0.18) were consistently synergistic against 14 clinical isolates of P. maltophilia.

MeSH Terms
Carbenicillin/pharmacology Drug Synergism Gentamicins/pharmacology Pseudomonas Rifampin/pharmacology Sulfamethoxazole/pharmacology Time Factors Trimethoprim/pharmacology
Chemicals
Gentamicins Trimethoprim Carbenicillin Sulfamethoxazole Rifampin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yu V L
Felegie T P
Yee R B
Pasculle A W
Taylor F H
Article Info
Journal
The Journal of infectious diseases
Abbr.
J Infect Dis
ISSN
0022-1899
Published
1980-10-00
Pages
602-7
Language
English
Region
United States
NLM ID
0413675
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]